Biotechnology must factor into a broader Canadian industrial policy

Governments should focus on supporting basic research, helping startups, and funding the scale-up of growth companies.

Tax policy also plays an important role in encouraging businesses to take the risks necessary for innovation, and Finance Minister Chrystia Freeland’s recent capital gains reforms discourage this, writes Frank Baylis. The Hill Times photograph by Andrew Meade

Opinion

BY FRANK BAYLIS

September 18, 2024

The 2024 Bloom Burton Awards underscore the strength of Canada’s biotechnology and life sciences sectors. The award honours an individual who has made the greatest contribution to Canada’s innovative health care industry. This year’s finalists are Roberto Bellini of Be...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy